Mason Michael
SEC CIK 1514291 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| KPTI | Karyopharm Therapeutics Inc. | EVP, CFO, Treas | 391.1K | — | $189.8K | 18 | 2022-02-07 | 2024-09-04 |
Most active insiders at KPTI, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Paulson Richard A. | Pres, CEO, Dir | — | $137.2K |
| 2 | Poulton Stuart | EVP, Chief Development Off | — | $56.4K |
| 3 | Rangwala Reshma | EVP, Chief Medical Off | — | $55.6K |
| 4 | Cheng Sohanya Roshan | EVP, Chief Commercial Off | — | $46.4K |
| 5 | Mano Michael | SVP, GC, Sec | — | $35.7K |
| 6 | Macomber Lori | EVP, CFO, Treas | — | $10.2K |
| 7 | Abate Kristin | CAO | — | $10.0K |
| 8 | Su Zhen | Dir | — | — |
| 9 | Oliger Christy J. | Dir | — | — |
| 10 | Schor Chen | Dir | — | — |
Mason Michael made no open-market trades at KPTI in the last 12 months.
Transactions 18
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-05 | 2024-09-04 | KPTI | Karyopharm Therapeutics Inc. | Mason Michael | EVP, CFO, Treas | S - Sale | $0.72 | -7,050 | 391.1K | -2% | -$5,076 | |
| 2024-06-06 | 2024-06-04 | KPTI | Karyopharm Therapeutics Inc. | Mason Michael | EVP, CFO, Treas | S - Sale | $0.99 | -652 | 398.1K | -0.2% | -$645.48 | |
| M | 2024-03-04 | 2024-02-29+ | KPTI | Karyopharm Therapeutics Inc. | Mason Michael | EVP, CFO, Treas | S - Sale | $1.18 | -33.8K | 404.9K | -8% | -$39.8K |
| 2024-02-29 | 2024-02-27 | KPTI | Karyopharm Therapeutics Inc. | Mason Michael | EVP, CFO, Treas | S - Sale | $1.32 | -2,545 | 244.4K | -1% | -$3,359 | |
| 2024-02-29 | 2024-02-28 | KPTI | Karyopharm Therapeutics Inc. | Mason Michael | EVP, CFO, Treas | A - Grant | $0.00 | +188.2K | 432.6K | +77% | $0 | |
| 2024-02-08 | 2024-02-06 | KPTI | Karyopharm Therapeutics Inc. | Mason Michael | EVP, CFO, Treas | S - Sale | $1.59 | -4,205 | 246.9K | -2% | -$6,686 | |
| 2024-01-25 | 2024-01-24 | KPTI | Karyopharm Therapeutics Inc. | Mason Michael | EVP, CFO, Treas | A - Grant | $0.00 | +13.3K | 251.2K | +6% | $0 | |
| 2023-09-05 | 2023-09-01 | KPTI | Karyopharm Therapeutics Inc. | Mason Michael | EVP, CFO, Treas | S - Sale | $1.33 | -6,913 | 237.8K | -3% | -$9,194 | |
| 2023-06-05 | 2023-06-02 | KPTI | Karyopharm Therapeutics Inc. | Mason Michael | EVP, CFO, Treas | S - Sale | $2.22 | -631 | 244.7K | -0.3% | -$1,401 | |
| 2023-03-02 | 2023-02-28 | KPTI | Karyopharm Therapeutics Inc. | Mason Michael | EVP, CFO, Treas | A - Grant | $0.00 | +95.0K | 256.6K | +59% | $0 | |
| 2023-03-02 | 2023-03-01 | KPTI | Karyopharm Therapeutics Inc. | Mason Michael | EVP, CFO, Treas | S - Sale | $3.03 | -11.2K | 245.4K | -4% | -$34.0K | |
| 2023-03-01 | 2023-02-27 | KPTI | Karyopharm Therapeutics Inc. | Mason Michael | EVP, CFO, Treas | S - Sale | $3.04 | -2,802 | 161.6K | -2% | -$8,518 | |
| 2023-02-08 | 2023-02-06 | KPTI | Karyopharm Therapeutics Inc. | Mason Michael | EVP, CFO, Treas | S - Sale | $3.40 | -4,141 | 164.4K | -2% | -$14.1K | |
| D | 2022-09-01 | 2022-08-31 | KPTI | Karyopharm Therapeutics Inc. | Mason Michael | EVP, CFO, Treas | A - Grant | $0.00 | +30.0K | 168.5K | +22% | $0 |
| M | 2022-06-06 | 2022-06-03 | KPTI | Karyopharm Therapeutics Inc. | Mason Michael | EVP, CFO, Treas | S - Sale | $6.04 | -601 | 138.5K | -0.4% | -$3,630 |
| D | 2022-03-02 | 2022-02-28 | KPTI | Karyopharm Therapeutics Inc. | Mason Michael | EVP, CFO, Treas | S - Sale | $10.24 | -2,398 | 139.1K | -2% | -$24.6K |
| D | 2022-03-02 | 2022-02-28 | KPTI | Karyopharm Therapeutics Inc. | Mason Michael | EVP, CFO, Treas | A - Grant | $0.00 | +88.2K | 141.5K | +165% | $0 |
| 2022-02-09 | 2022-02-07 | KPTI | Karyopharm Therapeutics Inc. | Mason Michael | EVP, CFO, Treas | S - Sale | $9.86 | -3,947 | 53.3K | -7% | -$38.9K |
Purchase Sale Sale after option exercise All abbreviations